Transcranial Magnetic Stimulation Therapy in Neuropathic Painful Spinal Cord Injury Patients
Effect of Repetative Transcranial Magnetic Stimulation Therapy on Neuropathic Pain in Patients With Spinal Cord Injury
1 other identifier
interventional
60
1 country
1
Brief Summary
The aim of our study is to investigate the effect of high-frequency Repetitive Transcranial Magnetic Stimulation(rTMS) therapy applied to the dorsolateral PFC (DLPFC) area on neuropathic pain in patients with spinal cord injury. In this area, there are very few studies on the effectiveness of rTMS treatment added to medical treatment in neuropathic pain. In addition, the number of studies comparing the effect of rTMS therapy applied to the DLFPC area is very few.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2022
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 15, 2022
CompletedFirst Submitted
Initial submission to the registry
December 1, 2022
CompletedFirst Posted
Study publicly available on registry
December 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2026
CompletedMarch 9, 2026
March 1, 2026
3.4 years
December 1, 2022
March 6, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline Visual Analog Scale (VAS) at 15 day and 6 week.
It is evaluated between 0-10. 10 means severe pain, 0 means no pain. Night and day VAS assessment will be questioned.
up to 6 week
Secondary Outcomes (5)
Change from baseline The Leeds Assessment of Neuropathic Symptoms & Signs Pain Scale(LANSS) at 15 day and 6 week.
up to 6 week
Change from baseline Short form McGill Pain questionnaire(SF-MPQ) at 15 day and 6 week.
up to 6 week
Change from baseline Short form 36 (SF-36) at 15 day and 6 week.
up to 6 week
Change from baseline Beck Depression Scale at 15 day and 6 week.
up to 6 week
Beck Anxiety Scale at 15 day and 6 week.
up to 6 week
Study Arms (2)
High-frequency real-time rTMS protocol
EXPERIMENTALIt was planned to apply a total of 1200 beats to the dorsolateral prefrontal cortex daily at a frequency of 10 HZ at 110% intensity of the motor threshold for 15 sessions.
Sham rTMS Protocol
SHAM COMPARATORIt was planned to apply daily sham rTMS to the dorsolateral prefrontal cortex for 15 sessions.
Interventions
It was planned to apply a total of 1200 beats to the dorsolateral prefrontal cortex daily for 15 sessions. Along with the daily rTMS session, patients will continue to use the drugs in the medical treatment (pregabalin, gabapentin, carbamazepine) at the same effective dose. No dose changes will be made during rTMS sessions.
It was planned to apply a to the dorsolateral prefrontal cortex daily for 15 sessions. Along with the daily rTMS session, patients will continue to use the drugs in the medical treatment (pregabalin, gabapentin, carbamazepine) at the same effective dose. No dose changes will be made during rTMS sessions.
Eligibility Criteria
You may qualify if:
- Between the ages of 20-70, who applied to the AFSU Physical Medicine and Rehabilitation inpatient service with the diagnosis of spinal cord injury and
- Having spinal cord injury with neurophatic pain at least six months ago,
- Able to follow two-stage verbal commands,
- Agreeing to participate in the study voluntarily and regularly,
- Patients who are medically stable (no previous myocardial infarction, no musculoskeletal problems) will be included in our study.
You may not qualify if:
- Having an important comorbid disease such as severe heart disease (aortic stenosis, angina, hypertrophic cardiomyopathy, arrhythmia, pacemaker) and uncontrolled hypertension,
- Epilepsy,
- History of antiepileptic drug use,
- Intracranial metal object,
- Presence of in-ear implant,
- Cognitive dysfunction,
- Lower extremity peripheral nerve injury,
- With malignancy and active infection,
- Infection on the skin in the application area,
- Having an open wound,
- Having inflammatory disease,
- Orthopedic injuries that can limit maximum effort contractions,
- Having a brain lesion or a history of drug use that will affect the seizure threshold,
- Patients with increased intracranial pressure or uncontrolled migraine will not be included.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Afyonkarahisar
Afyonkarahisar, 0300, Turkey (Türkiye)
Related Publications (3)
Nardone R, Holler Y, Langthaler PB, Lochner P, Golaszewski S, Schwenker K, Brigo F, Trinka E. rTMS of the prefrontal cortex has analgesic effects on neuropathic pain in subjects with spinal cord injury. Spinal Cord. 2017 Jan;55(1):20-25. doi: 10.1038/sc.2016.87. Epub 2016 May 31.
PMID: 27241450BACKGROUNDYang QH, Zhang YH, Du SH, Wang YC, Fang Y, Wang XQ. Non-invasive Brain Stimulation for Central Neuropathic Pain. Front Mol Neurosci. 2022 May 19;15:879909. doi: 10.3389/fnmol.2022.879909. eCollection 2022.
PMID: 35663263BACKGROUNDLi L, Huang H, Yu Y, Jia Y, Liu Z, Shi X, Wang F, Zhang T. Non-invasive Brain Stimulation for Neuropathic Pain After Spinal Cord Injury: A Systematic Review and Network Meta-Analysis. Front Neurosci. 2022 Feb 11;15:800560. doi: 10.3389/fnins.2021.800560. eCollection 2021.
PMID: 35221889BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nuran EYVAZ, MD
Afyonkarahisar Health Sciences University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
December 1, 2022
First Posted
December 9, 2022
Study Start
November 15, 2022
Primary Completion
March 31, 2026
Study Completion
March 31, 2026
Last Updated
March 9, 2026
Record last verified: 2026-03